IDIX IDX899: any guesstimate on when P2 results? Nope—GSK is running the show now on IDX899 and they alone control the disclosures. Will IDIX be @$3/share if the head to head results vs Sustiva are favorable? I presume your question is rhetorical. I think there’s a good chance IDIX won’t be an independent company by then.